Evidence map›Paper›PMID 22307978›Full record

ArticleJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2012

Multipotent progenitors resident in the skeletal muscle interstitium exhibit robust BMP-dependent osteogenic activity and mediate heterotopic ossification.

Michael N Wosczyna, Arpita A Biswas, Catherine A Cogswell, David J Goldhamer

Open access · bronzeAbstract read
In one paragraph

Article in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 194 papers.

0numbers the graph read from it
0cells of the map it votes in
194citing papers in PubMed
17.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

194 citing papers in PubMed, 318 citations in OpenAlex.

  1. Article
  2. Review
  3. Clec3bBone research · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Food science of animal resources · 2025
    Article
  17. Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  18. Review
  19. Article
  20. Article

134 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Michael N WosczynaDepartment of Molecular and Cell Biology, Center for Regenerative Biology, University of Connecticut Stem Cell Institute, University of Connecticut, Storrs, CT, USA.
Arpita A Biswas
Catherine A Cogswell
David J Goldhamer
University of Connecticut · US

Funding

The Cellular Basis of Heterotopic OssificationR01AR057371 · NIAMS · UNIVERSITY OF CONNECTICUT STORRS · PI GOLDHAMER, DAVID J · 2010 to 2014
$1.6M
NIAMS NIH HHS AR057371NIAMS NIH HHS R01 AR057371
6 · The paper itself

Abstract

Heterotopic ossification is a debilitating condition that can result from traumatic injury, surgery, or genetic disease. We investigated the cellular origins of heterotopic skeletogenesis in the mouse using lineage tracing and bioassays of heterotopic ossification based on intramuscular transplantation. We identified, characterized, and purified a tissue-resident stem/progenitor cell population that exhibits robust osteogenic potential and represents a major cell-of-origin for heterotopic ossification. These progenitors reside in the interstitium of skeletal muscle and other tissues, and are distinct from the endothelium, which does not exhibit osteogenic activity in response to bone morphogenetic protein 2 (BMP2) stimulation. Intramuscular transplantation, together with clonal analysis in culture, revealed that these progenitors are multipotent, exhibiting the capacity for both BMP-dependent skeletogenic differentiation and spontaneous adipogenic differentiation. Identifying the cells-of-origin responsible for heterotopic ossification provides a potential therapeutic target to treat, mitigate, or prevent this disabling condition.

Indexed as

Multipotent Stem CellsOssification, HeterotopicAdipogenesisAnimalsBone Morphogenetic Protein 2Cells, CulturedFlow CytometryFluorescent Antibody TechniqueGenotypeMiceMice, SCIDMuscle, SkeletalOsteogenesisReceptor Protein-Tyrosine KinasesReceptor, TIE-2Bmp2 protein, mouseBone Morphogenetic Protein 2Receptor Protein-Tyrosine KinasesReceptor, TIE-2Tek protein, mouse

Identifiers

PMID22307978
PMCPMC3361573
OpenAlexW2063445980

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.